 YAVNE, Israel, May 10, 2022 GLOBE NEWSWIRE -- MediWound Ltd. Nasdaq: MDWD, a fully integrated biopharmaceutical company focused on next-generation bio-therapeutic solutions for tissue repair and regeneration, today announced that the Company will release its financial results for the first quarter ended March 31, 2022 on Tuesday, May 17, 2022. 